The shortcomings of health care systems across Canada have been thrown into stark relief by the pandemic, with surgery backlogs making headlines again of late. A lack of physicians and the absence of competition between private and public providers is undermining access to care. This publication proposes several ways of improving access to health care, including expanding the role of independent providers and increasing the number of doctors in Quebec. For this to happen, however, the College of Physicians and the government will have to end their intimate connection that is harming Quebecers.

At the end of the day, we must avoid nationalizing dental care, and instead provide coverage for those who can’t afford it.

L’un des éléments du dernier budget fédéral ayant fait couler le plus d’encre est définitivement le nouveau programme visant l’élargissement de la couverture publique des soins dentaires.

Mardi dernier, le ministre de la Santé, Christian Dubé, nous présentait son plan de réforme du système de santé pour les prochaines années. Contrairement à la poutine habituelle, il a été notamment question de faire davantage de place au privé en santé.

This President’s Essay addresses the most contentious and pressing issue of our day: the COVID-19 pandemic and our response to it. Now that the pandemic seems to be subsiding, and government-imposed restrictions as well, it is a good time to look back and take a calm and measured look at some of the key issues that were raised by it.

March 30, 2022 | 10 min. 21 sec. | Point du jour (Ici Radio-Canada) Interview (in French) with Maria Lily Shaw, Economist […]

March 29, 2022 | 12 min. 01 sec. | Richard Martineau (QUB Radio) Interview (in French) with Maria Lily Shaw, Economist at […]

À l’heure où le ministre de la Santé s’apprête à déposer son plan pour une refonte du système de santé, un élément incontournable s’impose: l’augmentation du nombre de médecins conjuguée à des mesures permettant une meilleure utilisation des ressources existantes.

We Canadians like to think we lead the world when it comes to health care. The facts, however, tell a different story.

Leading up to the 2022 federal budget, one of the hopes of the pharmaceutical sector is that the government will repeal and rethink certain regulatory updates to the Patented Medicine Prices Review Board.